Showing results (261-270 of 274) with videos related to
Sort By:
Pageof 28
Leukemia|September 4, 2012
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic targetS A Hartsink-Segers, C M Zwaan, C Exalto, et al.Leukemia|February 24, 2001
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research HospitalC H Pui, J M Boyett, G K Rivera, et al.Clinical Pharmacology and Therapeutics|July 4, 2013
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancerJ J Yang, J Y S Lim, J Huang, et al.Pharmacogenetics|June 1, 1996
Nomenclature for human CYP2D6 allelesA K Daly, J Brockmöller, F Broly, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Infection-related complications during treatment for childhood acute lymphoblastic leukemiaH Inaba, D Pei, J Wolf, et al.Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprineW E Evans, Y Y Hon, L Bomgaars, et al.Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.Clinical Pharmacology and Therapeutics|August 27, 2016
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic TraitC Liu, W Yang, D Pei, et al.Pageof 28